751-800

Articles Published by the Ocular Immunology and Uveitis Foundation

C. Stephen Foster, M.D.

In Print (751-800)

Previous 50      Next 50

751. Comparison of two different combination immunosuppressive therapies in the treatment of Vogt-Koyonagi-Harada syndrome. Arcinue CA, Radwan A, Lebanan MO, Foster CS.  Ocul Immunol Inflamm. 2013;21(1):47-52.

752. Diagnostic criteria for primary ocular lymphoma.  Arcinue CA, Hochberg F, Neumann R, Foster CS. 2013 Mar;120(3):646-646.e2.

753. Secukinumab in the treatment of noninfectious uveitis: results of three randomized, controlled clinical trials. Dick AD, Foster CS. 2013 Apr;120(4):777-87.

754. A Comparison Between the Fluocinolone Acetonide (Retisert) and Dexamethasone (Ozurdex) Intravitreal Implants in Uveitis. Arcinue CA, Ceròn OM, Foster CS.  J Ocul Pharmacol Ther. 2013 Jun;29(5):501-7.

755. Suelves AM, Arcinue CA, Gonazalez-Martin JM, Kruh JN, Foster CS. Analysis of a novel protocol of pulsed intravenous cyclophosphamide for recalcitrant or severe ocular inflammatory disease.  2013 Jun;120(6):1201-9.

756. Diagnostic and Therapeutic Challenges. Tauqir MZ, Shulman M, Bittencourt M, Sepah YJ, Ibrahim M, Do DV, Nguyen QD, Foster CS, Vora RA, Albini TA. Retina. 2013 Apr;33(4):883-8.

757. Les Manifestations d’Oculaire des Troubles Rhumatologique et Vasculaire Potentiellements Fatals. Foster CS. Journal Français d’Ophthalmologie, Vol. 36(6). June 2013.

758.  Vision-Related Functioning Outcomes of Dexamethasone Intravitreal Implant in Noninfectious Intermediate or Posterior Uveitis. Lightman S, Belfot R, Naik RK, Lowder C, Foster CS, Rentz AM, Cui H, Whitcup SM, Kowalski JW, Revicki DA. Invest Ophthalmol Vis Sci. 2013 Jul 18;54(7):4864-70.

759. Response of Pediatric Uveitis to Tumor Necrosis Factor-α Inhibitors.  Lerman MA, Burnham JM, Chang PY, Daniel E, Foster CS, Hennessy S, Jabs DA, Joffe MM, Kaçmaz RO, Levy-Clarke GA, Mills MD, Nussenblatt RB, Rosenbaum JT, Suhler EB, Thorne JE, Kempen JH.  J Rheumatol. 2013 Aug;40(8):1394-403.

760. Cytomegalovirus Retinitis in Immunocompetent Patients: Case Reports and Literature Review Ocul Immunol Inflamm.Radwan A, Metzinger JL, Hinkle DM, Foster CS. 2013 Aug;21(4):324-8.

761. Bajwa A, Foster CS. Diagnostic Testing of Primary Vitreo-Retinal Lymphoma.  Journal of Analytical Oncology, Vol. 2(3).  August 2013.

762. Interleukin-21, Interleukin-23, and Transforming Growth Factor-β1 in HLA-A29-Associated Birdshot Retinochoroidopathy. Yang P, Foster CS. Am J Ophthalmol. 2013 Aug;156(2):400-406.e2.

763. Risk of elevated intraocular pressure and glaucoma in patients with uveitis: results of the multicenter uveitis steroid treatment trial. Friedman DS, Holbrook JT, Ansari H, Alexander J, Burke A, Reed SB, Katz J, Thorne JE, Lightman SL, Kempen JH; MUST Research Group. Ophthalmology. 2013 Aug;120(8):1571-9.

764. Risk of choroidal neovascularization among the uveitides. Baxter SL, Pistilli M, Pujari SS, Liesegang TL, Suhler EB, Thorne JE, Foster CS, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Kempen JH. Am J Ophthalmol. 2013 Sep;156(3):468-77.e2.

765. Fluorescein Angiography versus Optical Coherence Tomography for Diagnosis of Uveitic Macular Edema. Kempen JH, Sugar EA, Jaffe GJ, Acharya NR, Dunn JP, Elner SG, Lightman SL, Thorne JE, Vitale AT, Altaweel MM, for the MUST Trial Research Group. 2013 Sep;120(9):1852-9.

766. Risk factors associated with the relapse of uveitis in patients with juvenile idiopathic arthritis: a preliminary report. Saboo US, Metzinger JL, Radwan A, Arcinue CA, Parikh R, Mohamed A, Foster CS. J AAPOS. 2013 Oct;17(5):460-4.

767. HLA Associations in Chronic Vision Threatening Uveitis. Sarup V, Foster CS. Semin Ophthalmol. 2013 Sep-Nov;28(5-6):333-6.

768. Metzinger JL, Foster CS. Emerging therapies for the treatment of uveitis: clinical trial observations.  Clin Investigation. 2013 Oct; 3(10):951-66.

769. Endoftalmitis Infecciosa Endógena Pediátrica: Reto Diagnóstico y Revisión de la Literatura. Rodríguez-García A, Foster CS, González-Díaz MP, Larrazabal-Aguerrevere LI. Rev Mex Infecc & Infectol. 2013 August ;33(4):174-82.

770. Recent Advances in Uveitic Glaucoma. Metzinger JL, Cerón O, Foster CS.  Glaucoma Now, 2013 3.

771. Identification of Epitopes within Integrin β4 for Binding of Autoantibodies in Ocular Cicatricial and Mucous Membrane Pemphigoid – Preliminary Report. Rashid KA, Foster CS, Ahmed AR.  Invest Ophthalmol Vis Sci. 2013 Nov 19;54(12):7707-16.

772. Arcinue CA, Foster CS. Ocular Toxoplasmosis.  Highlights of Ophthalmology, English Edition, Issue 4.

773. Arcinue CA, Foster CS. Ocular Toxoplasmosis.  Highlights of Ophthalmology, English – Middle East Edition, Issue 4.

774. Arcinue CA, Foster CS. Ocular Toxoplasmosis.  Highlights of Ophthalmology, English – Indian Edition, Issue 3.

775. Arcinue CA, Foster CS. Ocular Toxoplasmosis.  Highlights of Ophthalmology, Italian Edition, Issue 4.

776. Arcinue CA, Foster CS. Ocular Toxoplasmosis.  Highlights of Ophthalmology, Spanish Edition, Issue 4.

777. Arcinue CA, Foster CS. Ocular Toxoplasmosis.  Highlights of Vitreoretina (Spanish), Issue 3.

778. Use of intravitreal rituximab for treatment of vitreoretinal lymphoma.  Larkin KL, Saboo US, Comer GM, Forooghian F, Mackensen F, Merrill P, Sen HN, Singh A, Essex RW, Lake S, Lim LL, Vasconcelos-Santos DV, Foster CS, Wilson DJ, Smith JR. Br J Ophthalmol. 2014 Jan;98(1):99-103.

779. Neutrophil Collagenase, Gelatinase, and Myeloperoxidase in Tears of Patients with Stevens-Johnson Syndrome and Ocular Cicatricial Pemphigoid. Arafat SN, Suelves AM, Spurr-Michaud S, Chodosh J, Foster CS, Dohlman CH, Gipson IK. Ophthalmology. 2014 Jan;121(1):79-87.

780. Infliximab for the Treatment of Refractory Noninfectious Uveitis: A Study of 88 Patients with Long-Term Follow-Up. Kruh JN, Yang P, Suelves AM, Foster CS. 2014 Jan;121(1):358-64.

781.  Anterior chamber intraocular lens implantation in patients with a history of chronic uveitis: Five-year follow-up. Suelves AM, Siddique SS, Schurko B, Foster CS.  J Cataract Refract Surg. 2014 Jan;40(1):77-81.

782. Disease of the Year: Juvenile Idiopathic Arthritis – Differential Diagnosis. Hu-Torres S, Foster CS.  Ocul Immunol Inflamm. 2014 Feb;22(1):42-55.

783. Incidence of Visual Improvement in Uveitis Cases with Visual Impairment Caused by Macular Edema. Levin MH, Pistilli M, Daniel E, Gangaputra SS, Nussenblatt RB, Rosenbaum JT, Suhler EB, Thorne JE, Foster CS, Jabs DA, Levy-Clarke GA, Kempen JH. 2014 Feb;121(2):588-95.e1.

784. Ocular Manifestations of Systemic Lupus Erythematosus. Bajwa A, Foster CS.  J Clin Cell Immunol, 2014 Feb;5(1).

785. Factors predictive of remission of new-onset anterior uveitis.  Artornsombudh P, Pistilli M, Foster CS, Pujari SS, Gangaputra SS, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Suhler EB, Thorne JE, Kempen JH. 2014 Mar;121(3):778-84.

786. Review of Systemic Immunosuppression for Autoimmune Uveitis.  Castiblanco C, Foster CS. Ophthalmol Ther. 2014 Mar 18.

787. Difluprednate 0.05% Versus Prednisolone Acetate 1% for Endogenous Anterior Uveitis: A Phase III, Multicenter, Randomized Study.  Sheppard JD, Toyos MM, Kempen JH, Kaur P, Foster CS. Invest Ophthalmol Vis Sci. 2014 May 6;55(5):2993-3002.

788.  Clinical Features and Presentation of Posterior Scleritis: A Report of 31 Cases. Gonzalez-Gonzalez LA, Molina-Prat N, Doctor P, Tauber J, Sainz de la Maza M, Foster CS. Ocul Immunol Inflamm. 2014 Jun;22(3):203-7.

789. Management of Pediatric Uveitis . Wentworth BA, Freitas-Neto C, Foster CS. F1000Prime Rep. 2014; 6: 41.

790. Ocular Cicatricial Pemphigoid. Foster CS.  Ophthalmolog Management, Special Report Cornea. 2014 Aug;18(8):8-9.

791. A comprehensive review and update on the non-biologic treatment of adult noninfectious uveitis: part I. Lee K, Bajwa A, Freitas-Neto CA, Metzinger JL, Wentworth BA, Foster CS.  Expert Opin Pharmacother. 2014 Oct;15(15):2141-54.

792.  A comprehensive review and update on the biologic treatment of adult noninfectious uveitis: part II. Lee K, Bajwa A, Freitas-Neto CA, Metzinger JL, Wentworth BA, Foster CS.  Expert Opin Biol Ther. 2014 Nov;14(11):1651-66.

793. Cost-effectiveness of fluocinolone acetonide implant versus systemic therapy for noninfectious intermediate, posterior, and panuveitis.  Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group, Sugar EA, Holbrook JT, Kempen JH, Burke AE, Drye LT, Thorne JE, Louis TA, Jabs DA, Altaweel MM, Frick KD. Ophthalmology. 2014 Oct;121(10):1855-62.

794. Safety and efficacy of fluocinolone acetonide intravitreal implant (0.59 mg) in birdshot retinochoroidopathy. Bajwa A, Aziz K, Foster CS. 2014 Nov;34(11):2259-68.

795. Periocular Corticosteroid Injections in Uveitis: Effects and Complications.  Sen HN, Vitale S, Gangaputra SS, Nussenblatt RB, Liesegang TL, Levy-Clarke GA, Rosenbaum JT, Suhler EB, Thorne JE, Foster CS, Jabs DA, Kempen JH. 2014 Nov;121(11):2275-86.

796. Optic Neuritis Complicating Herpes Zoster Opthalmicus in an Immunocompetent Patient. Freitas-Neto CA, Cerón O, Pacheco KD, Pereira VO, Ávila MP, Foster CS.  Revista Brasileira de Oftalmologia. 2014 Nov-Dec:73(6);386-388.

797. Subconjunctival Indocyanine Green Identifies Lymphatic Vessels. Freitas-Neto CA, Costa RA, Kombo N, Freitas T, Oréfice JL, Oréfice F, Foster CS.  JAMA Ophthalmol. 2015 Jan;133(1):102-4.

798. Lack of Consensus in the Diagnosis and Treatment of Ocular Tuberculosis among Uveitis Specialists. Lou SM, Larkin KL, Winthrop K, Rosenbaum JT, and members of the Uveitis Specialists Study Group. Ocul Immunol Inflamm. 2015 Feb;23(1):25-31.

799. Birdshot retinochoroidopathy review. Freitas-Neto CA, Boonsopon S, Dhanireddy S, Maghsoudlou A, Silpa-Archa S, Foster CS.  Arq Bras Oftalmol. 2015 Jan-Feb;78(1):56-61.

800. Ocular Manifestations in Systemic Lupus Erythematosus. Boonsopon S, Maghsoudlou A, Foster CS. Rheumatology (Sunnyvale). 2015 Mar; 5(1).

Previous 50      Next 50

  • Online Physician Forum

    Our Online Physician Forum is currently under development. Please check back periodically.
  • Twitter Feed